Does comorbidity explain the ethnic inequalities in cervical cancer survival in New Zealand? A retrospective cohort study.

PubWeight™: 0.91‹?›

🔗 View Article (PMC 3087712)

Published in BMC Cancer on April 12, 2011

Authors

Naomi Brewer1, Barry Borman, Diana Sarfati, Mona Jeffreys, Steven T Fleming, Soo Cheng, Neil Pearce

Author Affiliations

1: Centre for Public Health Research, Massey University, PO Box 756, Wellington 6140, New Zealand. n.brewer@massey.ac.nz

Articles cited by this

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis (1987) 174.79

Comorbidity measures for use with administrative data. Med Care (1998) 46.67

Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care (2005) 30.41

Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA (2004) 5.93

Risk adjustment in outcome assessment: the Charlson comorbidity index. Methods Inf Med (1993) 2.87

Measuring cancer survival in populations: relative survival vs cancer-specific survival. Int J Epidemiol (2010) 2.48

Impact of comorbidity on lung cancer survival. Int J Cancer (2003) 1.95

Length of comorbidity lookback period affected regression model performance of administrative health data. J Clin Epidemiol (2006) 1.69

Comorbidity as a predictor of stage of illness for patients with breast cancer. Med Care (2005) 1.55

Survival disparities in Indigenous and non-Indigenous New Zealanders with colon cancer: the role of patient comorbidity, treatment and health service factors. J Epidemiol Community Health (2010) 1.18

Ethnic inequalities in cancer survival in New Zealand: linkage study. Am J Public Health (2005) 1.08

Unlocking the numerator-denominator bias III: adjustment ratios by ethnicity for 1981-1999 mortality data. The New Zealand Census-Mortality Study. N Z Med J (2003) 1.07

How well does routine hospitalisation data capture information on comorbidity in New Zealand? N Z Med J (2010) 0.98

Ethnic disparities in cervical cancer survival among Medicare eligible women in a multiethnic population. Int J Gynecol Cancer (2009) 0.93

Stage IB squamous cell cancer of the cervix: clinicopathologic features related to survival. Am J Obstet Gynecol (1991) 0.90

Demographic differences in stage at diagnosis and cervical cancer survival in New Zealand, 1994-2005. J Womens Health (Larchmt) (2009) 0.90

Improving survival disparities in cervical cancer between Māori and non-Māori women in New Zealand: a national retrospective cohort study. Aust N Z J Public Health (2010) 0.89

Predictors of outcomes for women with cervical carcinoma. Gynecol Oncol (2005) 0.89

Comorbidities and the risk of late-stage prostate cancer. ScientificWorldJournal (2006) 0.85

Prognostic value of clinical variables in invasive cervical cancer. Obstet Gynecol (1994) 0.84

Does screening history explain the ethnic differences in stage at diagnosis of cervical cancer in New Zealand? Int J Epidemiol (2009) 0.82

Management of stages I and II non-small-cell lung cancer in a New Zealand study: divergence from international practice and recommendations. Intern Med J (2008) 0.79

Determinants of inequalities in cervical cancer stage at diagnosis and survival in New Zealand. Cancer Causes Control (2009) 0.79

Comorbidity and age affect treatment policy for cervical cancer: a population-based study in the south of The Netherlands, 1995-2004. Eur J Gynaecol Oncol (2008) 0.79

Co-morbidity and health outcomes in three Auckland hospitals. N Z Med J (2002) 0.77

Articles by these authors

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 50.94

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95

Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Birth weight and risk of type 2 diabetes: a systematic review. JAMA (2008) 6.73

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 6.13

UK health performance: findings of the Global Burden of Disease Study 2010. Lancet (2013) 6.11

[Corporate influences on epidemiology]. Epidemiol Prev (2008) 4.59

Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers. J Clin Oncol (2011) 2.65

Maternal complications and procedures in pregnancy and at birth and wheezing phenotypes in children. Am J Respir Crit Care Med (2006) 2.56

Effects of self-reported racial discrimination and deprivation on Māori health and inequalities in New Zealand: cross-sectional study. Lancet (2006) 2.49

Measuring cancer survival in populations: relative survival vs cancer-specific survival. Int J Epidemiol (2010) 2.48

The INTERPHONE study: design, epidemiological methods, and description of the study population. Eur J Epidemiol (2007) 2.30

Chronic bronchitis, COPD, and lung function in farmers: the role of biological agents. Chest (2009) 1.98

How to substantially increase recruitment in cancer trials in New Zealand. N Z Med J (2013) 1.95

Cancer disparities in indigenous Polynesian populations: Māori, Native Hawaiians, and Pacific people. Lancet Oncol (2008) 1.81

Racism and health: the relationship between experience of racial discrimination and health in New Zealand. Soc Sci Med (2006) 1.77

Gender differences in occupational exposure patterns. Occup Environ Med (2011) 1.72

Socio-economic factors and mortality among 25-64 year olds followed from 1991 to 1994: the New Zealand Census-Mortality Study. N Z Med J (2002) 1.70

Antibiotic sales and the prevalence of symptoms of asthma, rhinitis, and eczema: The International Study of Asthma and Allergies in Childhood (ISAAC). Int J Epidemiol (2004) 1.68

Tackling non-communicable diseases in low- and middle-income countries: is the evidence from high-income countries all we need? PLoS Med (2013) 1.67

Is hypertension associated with job strain? A meta-analysis of observational studies. Occup Environ Med (2013) 1.60

Can bacterial endotoxin exposure reverse atopy and atopic disease? J Allergy Clin Immunol (2004) 1.54

Burden of common multiple-morbidity constellations on out-of-pocket medical expenditures among older adults. Gerontologist (2007) 1.50

A New Zealand linkage study examining the associations between A1C concentration and mortality. Diabetes Care (2008) 1.48

Temporal trends in the incidence of childhood leukemia, lymphomas and solid tumors in north-west Italy, 1967-2001. A report of the Childhood Cancer Registry of Piedmont. Haematologica (2005) 1.48

Varying evolution of the New Zealand lung cancer epidemic by ethnicity and socioeconomic position (1981-1999). N Z Med J (2005) 1.46

A comparison of two skin test methodologies and allergens from two different manufacturers. Ann Allergy Asthma Immunol (2002) 1.45

Commentary: The end of the hygiene hypothesis? Int J Epidemiol (2008) 1.45

Feasibility of recruiting a birth cohort through the Internet: the experience of the NINFEA cohort. Eur J Epidemiol (2007) 1.42

A test-negative design with additional population controls can be used to rapidly study causes of the SARS-CoV-2 epidemic. Epidemiology (2020) 1.40

Mortality rates according to occupation in New Zealand males: 2001-2005. N Z Med J (2011) 1.39

Projected costs of colorectal cancer treatment in New Zealand in the absence of population screening. N Z Med J (2015) 1.38

Commentary: Representativeness is usually not necessary and often should be avoided. Int J Epidemiol (2013) 1.37

Epidemiology, public health, and the rhetoric of false positives. Environ Health Perspect (2009) 1.37

Prevention and control of diabetes in Pacific people. BMJ (2003) 1.36

Quality of cancer registry data: findings from CDC-NPCR's Breast and Prostate Cancer Data Quality and Patterns of Care Study. J Registry Manag (2011) 1.35

European experience of laparoscopic major hepatectomy. J Hepatobiliary Pancreat Sci (2013) 1.33

Infections, medication use, and the prevalence of symptoms of asthma, rhinitis, and eczema in childhood. J Epidemiol Community Health (2004) 1.30

Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a population-based study in England, 2004-2008. Gut (2012) 1.29

Asthma and the westernization 'package'. Int J Epidemiol (2002) 1.25

Self-reported truck traffic on the street of residence and symptoms of asthma and allergic disease: a global relationship in ISAAC phase 3. Environ Health Perspect (2009) 1.23

Associations between tooth loss and mortality patterns in the Glasgow Alumni Cohort. Heart (2006) 1.21

Case-control studies: basic concepts. Int J Epidemiol (2012) 1.20

Compression, expansion, or dynamic equilibrium? The evolution of health expectancy in New Zealand. J Epidemiol Community Health (2004) 1.19

Antibiotic use in infancy and symptoms of asthma, rhinoconjunctivitis, and eczema in children 6 and 7 years old: International Study of Asthma and Allergies in Childhood Phase III. J Allergy Clin Immunol (2009) 1.19

Do lifestyle or social factors explain ethnic/racial inequalities in breast cancer survival? Epidemiol Rev (2009) 1.19

Survival disparities in Indigenous and non-Indigenous New Zealanders with colon cancer: the role of patient comorbidity, treatment and health service factors. J Epidemiol Community Health (2010) 1.18

Invited commentary: is indoor mold exposure a risk factor for asthma? Am J Epidemiol (2003) 1.18

If nobody smoked tobacco in New Zealand from 2020 onwards, what effect would this have on ethnic inequalities in life expectancy? N Z Med J (2010) 1.15

Complications with Angio-Seal™ vascular closure devices compared with manual compression after diagnostic cardiac catheterization and percutaneous coronary intervention. J Interv Cardiol (2013) 1.13

Complexity, simplicity, and epidemiology. Int J Epidemiol (2006) 1.11

Recent trends in survival of adult patients with acute leukemia: overall improvements, but persistent and partly increasing disparity in survival of patients from minority groups. Haematologica (2012) 1.09

Case-control study of high risk occupations for bladder cancer in New Zealand. Int J Cancer (2008) 1.09

Differences in citation rates by country of origin for papers published in top-ranked medical journals: do they reflect inequalities in access to publication? J Epidemiol Community Health (2009) 1.09

Point: Incident Exposures, Prevalent Exposures, and Causal Inference: Does Limiting Studies to Persons Who Are Followed From First Exposure Onward Damage Epidemiology? Am J Epidemiol (2015) 1.08

Ethnic inequalities in cancer survival in New Zealand: linkage study. Am J Public Health (2005) 1.08

Selection bias and patterns of confounding in cohort studies: the case of the NINFEA web-based birth cohort. J Epidemiol Community Health (2011) 1.06

The hygiene hypothesis in allergy and asthma: an update. Curr Opin Allergy Clin Immunol (2013) 1.05

Sample selection and validity of exposure-disease association estimates in cohort studies. J Epidemiol Community Health (2010) 1.05

Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort. Neurology (2013) 1.02

Cancer incidence in four pacific countries: Tonga, Fiji Islands, Cook Islands and Niue. Pac Health Dialog (2011) 1.02

Socioeconomic inequalities in cancer survival in New Zealand: the role of extent of disease at diagnosis. Cancer Epidemiol Biomarkers Prev (2009) 1.01

Indigenous inequalities in cancer: what role for health care? ANZ J Surg (2012) 1.01

Statistical foundations for model-based adjustments. Annu Rev Public Health (2015) 1.01

Mortality from lung cancer in workers exposed to sulfur dioxide in the pulp and paper industry. Environ Health Perspect (2002) 1.00

Childhood socioeconomic circumstances predict specific causes of death in adulthood: the Glasgow student cohort study. J Epidemiol Community Health (2006) 1.00

Associations of type 2 diabetes and diabetes treatment with breast cancer risk and mortality: a population-based cohort study among British women. Cancer Causes Control (2012) 1.00

Social class mortality differences in Maori and non-Maori men aged 15-64 during the last two decades. N Z Med J (2002) 0.99

Cohort profile: the Boston Area Community Health (BACH) survey. Int J Epidemiol (2012) 0.99

Young adulthood body mass index and risk of cancer in later adulthood: historical cohort study. Cancer Causes Control (2010) 0.98

Socio-economic position is more than just NZDep. N Z Med J (2002) 0.98

Missing heritability in genome-wide association study research. Nat Rev Genet (2010) 0.98

Cancer in Pacific people in New Zealand: a descriptive study. Pac Health Dialog (2004) 0.98

Regional, provider, and economic factors associated with the choice of active surveillance in the treatment of men with localized prostate cancer. J Natl Cancer Inst Monogr (2012) 0.97

Exposure and dose modelling in occupational epidemiology. Occup Environ Med (2007) 0.97

The association of active smoking with multiple cancers: national census-cancer registry cohorts with quantitative bias analysis. Cancer Causes Control (2013) 0.96

Recent improvement in survival of patients with multiple myeloma: variation by ethnicity. Leuk Lymphoma (2013) 0.96

Incidence rates in dynamic populations. Int J Epidemiol (2012) 0.95

Social inequalities or inequities in cancer incidence? Repeated census-cancer cohort studies, New Zealand 1981-1986 to 2001-2004. Cancer Causes Control (2011) 0.95

Ethnicity and management of colon cancer in New Zealand: do indigenous patients get a worse deal? Cancer (2010) 0.95

Respiratory symptoms in children living near busy roads and their relationship to vehicular traffic: results of an Italian multicenter study (SIDRIA 2). Environ Health (2009) 0.93

Regional variations in asthma hospitalisations among Maori and non-Maori. N Z Med J (2004) 0.93

Ethnic and socioeconomic trends in breast cancer incidence in New Zealand. BMC Cancer (2010) 0.93

Lung cancer and occupation: A New Zealand cancer registry-based case-control study. Am J Ind Med (2010) 0.92

Prevalence of undiagnosed metabolic syndrome in a population of adult asymptomatic subjects. Diabetes Res Clin Pract (2006) 0.92

Prognostic factors in women with breast cancer: inequalities by ethnicity and socioeconomic position in New Zealand. Cancer Causes Control (2007) 0.90